Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 169M 148M 140M 128M 239M 16.21B 241M 1.68B 650M 8.28B 635M 621M 26.61B | P/E 2026 * |
-1.01x | P/E 2027 * | -1.49x |
|---|---|---|---|---|---|
| Enterprise Value | 169M 148M 140M 128M 239M 16.21B 241M 1.68B 650M 8.28B 635M 621M 26.61B | EV / Sales 2026 * |
3.07x | EV / Sales 2027 * | 1.53x |
| Free-Float |
99.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 169M | |
| +0.13% | +2.65% | +63.34% | +115.27% | 1,055B | |
| +0.20% | +0.46% | +50.92% | +72.63% | 654B | |
| -0.29% | +0.14% | +19.82% | +72.62% | 467B | |
| -0.85% | +0.98% | +42.13% | +42.98% | 348B | |
| +0.71% | +4.08% | +21.75% | +29.57% | 275B | |
| +1.23% | +0.42% | +14.11% | +12.90% | 258B | |
| +2.11% | +7.51% | +51.88% | +54.14% | 224B | |
| +0.83% | +0.55% | +34.64% | +99.77% | 187B | |
| 0.00% | -10.14% | -27.40% | -60.93% | 171B | |
| Average | +8.75% | +0.74% | +30.13% | +48.77% | 404.26B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.43% | +68.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55M 48.27M 45.58M 41.54M 77.76M 5.27B 78.32M 545M 211M 2.69B 207M 202M 8.66B | 111M 97.3M 91.9M 83.75M 157M 10.63B 158M 1.1B 426M 5.43B 416M 407M 17.45B |
| Net income | -169M -148M -140M -127M -239M -16.17B -240M -1.67B -648M -8.26B -634M -620M -26.55B | -164M -144M -136M -124M -232M -15.75B -234M -1.63B -631M -8.04B -617M -604M -25.86B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
